Previous Blogs


By Lynn Yao

四月 13, 2020

The Standing Committee of the National People’s Congress in China passed the revised Drug Administration Law (Revised Law) on 26-Aug-19. Effective 1-Dec-19, it is the first overhaul since 2001.The Revised Law addresses the major issues in the pharmaceutical industry, demonstrating the government’s efforts in strengthening supervision to ensure drug safety.

Analytical Labs

By Lynn Yao

四月 03, 2020


Fran is presenting

By Qian Lui

二月 28, 2018

It has been over a year since China Food and Drug Administration (CFDA) announced Matters Concerning Bundling Review and Approval of Pharmaceutical Packaging Materials, Pharmaceutical Excipients and Drugs (Document No.134 [2016]). As a result, the China pharmaceutical packaging industry is experiencing a revolution.

an expert from CFDA Jinan Quality Inspection Center for Pharmaceutical Packaging Materials spoke about preparation of a guidance for stability studies.

By Lynn Yao

一月 26, 2018

In 2016, the China Federal Drug Administration (CFDA) made two announcements regarding packaging of parenteral drug products. Per these announcements, stability studies of packaging materials should refer to protection, compatibility, safety and functionality properties.

Fran DeGrazio presents in China

By Lynn Yao

一月 02, 2018

Effective change control systems are important for pharmaceutical packaging materials – especially those in direct contact with drugs. This topic has high visibility in the China pharmaceutical packaging industry as a new change control strategy for pharmaceutical packaging materials is coming.